- Home
- TVTX vs PDX Comparison
TVTX vs PDX Comparison
Compare TVTX & PDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TVTX
- PDX
- Stock Information
- Founded
- TVTX 2008
- PDX 2019
- Country
- TVTX United States
- PDX NY
- Employees
- TVTX N/A
- PDX N/A
- Industry
- TVTX Biotechnology: Pharmaceutical Preparations
- PDX Finance/Investors Services
- Sector
- TVTX Health Care
- PDX Finance
- Exchange
- TVTX Nasdaq
- PDX Nasdaq
- Market Cap
- TVTX 1.4B
- PDX 1.1B
- IPO Year
- TVTX N/A
- PDX N/A
- Fundamental
- Price
- TVTX $14.53
- PDX $24.91
- Analyst Decision
- TVTX Strong Buy
- PDX
- Analyst Count
- TVTX 15
- PDX 0
- Target Price
- TVTX $33.57
- PDX N/A
- AVG Volume (30 Days)
- TVTX 1.6M
- PDX N/A
- Earning Date
- TVTX 07-31-2025
- PDX 01-01-0001
- Dividend Yield
- TVTX N/A
- PDX 4.95%
- EPS Growth
- TVTX N/A
- PDX N/A
- EPS
- TVTX N/A
- PDX N/A
- Revenue
- TVTX $273,533,000.00
- PDX N/A
- Revenue This Year
- TVTX $73.84
- PDX N/A
- Revenue Next Year
- TVTX $46.72
- PDX N/A
- P/E Ratio
- TVTX N/A
- PDX N/A
- Revenue Growth
- TVTX 75.65
- PDX N/A
- 52 Week Low
- TVTX $6.80
- PDX $13.52
- 52 Week High
- TVTX $25.29
- PDX $21.05
- Technical
- Relative Strength Index (RSI)
- TVTX 40.17
- PDX 73.31
- Support Level
- TVTX $13.88
- PDX $24.63
- Resistance Level
- TVTX $15.04
- PDX $25.25
- Average True Range (ATR)
- TVTX 0.67
- PDX 0.43
- MACD
- TVTX 0.04
- PDX 0.06
- Stochastic Oscillator
- TVTX 36.93
- PDX 85.42
About TVTX Travere Therapeutics Inc.
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.
About PDX PIMCO Dynamic Income Strategy Fund of Beneficial Interest
PIMCO Dynamic Income Strategy Fund is a non-diversified, limited term, closed-end management investment company registered under the Investment Company. The fund's primary investment objective is to seek current income as a primary objective and capital appreciation as a secondary objective.